NuSkin Enterprises (NUS)

NYSE Marked lukket

Nu Skin Enterprises, Inc. is a global beauty and wellness company that develops, markets, and sells personal care products, nutritional supplements, and related consumer technologies. The company is best known for the Nu Skin brand, which spans skin care, beauty devices, and anti-aging products, and Pharmanex, its wellness and nutrition line. Its products are distributed internationally through a direct selling model supported by independent sales leaders, social commerce tools, and local market operations.

Nu Skin reports its business across a broad geographic footprint that includes the Americas, Mainland China, Southeast Asia/Pacific, Japan, South Korea, Europe & Africa, and Hong Kong/Taiwan. This structure reflects the company’s reliance on local consumer preferences, regulatory environments, and distributor networks in each region. The Americas segment is a particularly important contributor, and wellness products represent a major part of total revenue.

Beyond its core branded consumer business, Nu Skin operates Rhyz, a strategic investment and operating platform. Rhyz includes manufacturing and packaging assets that support product development and supply chain capabilities, as well as other investments intended to broaden the company’s commercial reach. This gives Nu Skin exposure not only to consumer-facing beauty and wellness categories, but also to parts of the production infrastructure behind them.

The company competes in markets shaped by health-conscious consumers, premium skin care demand, and the growth of digital selling. Its performance depends on product innovation, brand engagement, distributor productivity, and the ability to navigate changing rules for direct selling and consumer products across global markets.

5.37 USD
5.19 USD
+0.05 (+0.94%)
Efter luk

Sidst opdateret

Markedsværdi
260.72M
P/E-forhold
4.78
P/FCF-forhold
6.27
P/S-forhold
0.18
Selskabsværdi
285.66M
Sektor
Health Care
Branche
Drugs, Drug Proprietaries, and Druggists' Sundries
Adresse
75 WEST CENTER ST, PROVO, UT, 84601
GlobeNewswire Inc.

Global Derma Roller Market Size To Worth USD 668.17 Million By 2033 | CAGR OF 8.22%

10. sep. 2024, 00:00 AM
Zacks Investment Research

Nu Skin (NUS) Up 5.6% Since Last Earnings Report: Can It Continue?

07. jun. 2024, 17:30 PM
Zacks Investment Research

Nu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes

09. maj 2024, 16:23 PM
Zacks Investment Research

Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates

09. maj 2024, 01:00 AM
Zacks Investment Research

Why Is Inter Parfums (IPAR) Down 4.1% Since Last Earnings Report?

28. mar. 2024, 16:30 PM
Zacks Investment Research

Nu Skin (NUS) Down 7.2% Since Last Earnings Report: Can It Rebound?

15. mar. 2024, 16:30 PM
Zacks Investment Research

Nu Skin (NUS) Q4 Earnings Top Estimates, Revenues Decline Y/Y

15. feb. 2024, 13:51 PM
Zacks Investment Research

Nu Skin Enterprises (NUS) Surpasses Q4 Earnings and Revenue Estimates

15. feb. 2024, 00:20 AM
Zacks Investment Research

Things to Consider Ahead of Nu Skin's (NUS) Q4 Earnings

12. feb. 2024, 13:49 PM
Zacks Investment Research

Philip Morris (PM) Lags Q4 Earnings Estimates

08. feb. 2024, 14:15 PM
Zacks Investment Research

Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for

07. feb. 2024, 16:00 PM
Zacks Investment Research

Nu Skin (NUS) Down More Than 20% in 3 Months: Here's Why

13. dec. 2023, 18:50 PM
Zacks Investment Research

Why Is Inter Parfums (IPAR) Up 2.8% Since Last Earnings Report?

07. dec. 2023, 17:31 PM
Zacks Investment Research

Nu Skin (NUS) Up 1% Since Last Earnings Report: Can It Continue?

01. dec. 2023, 17:32 PM
Zacks Investment Research

Nu Skin (NUS) Misses Q3 Earnings Estimates, Lowers Guidance

02. nov. 2023, 16:44 PM
Zacks Investment Research

Why Nu Skin (NUS) Could Beat Earnings Estimates Again

30. okt. 2023, 17:10 PM
Zacks Investment Research

e.l.f. Beauty (ELF) Readies for Q2 Earnings: Is a Beat Likely?

30. okt. 2023, 16:05 PM
Zacks Investment Research

Things to Note Ahead of Nu Skin's (NUS) Q3 Earnings

30. okt. 2023, 14:06 PM
Zacks Investment Research

Nu Skin Enterprises (NUS) Reports Next Week: Wall Street Expects Earnings Growth

25. okt. 2023, 16:02 PM
Zacks Investment Research

Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt

10. okt. 2023, 15:10 PM
Markedsværdi
260.72M
Selskabsværdi
285.66M
P/E-forhold
4.78
P/B-forhold
0.33
P/S-forhold
0.18
SV / EBITDA
2.17
SV / salg
0.2
Indtjening pr. aktie
1.12
Udbytteafkast
6.98%
P/FCF-forhold
6.27
P/CF-forhold
3.43
Fri pengestrøm
41.57M
Afkast på egenkapital
6.87%
Afkast på aktiver
3.96%
Gæld / egenkapital
0.28
Likviditetsgrad
2.03
Hurtig likviditetsgrad
1.34
Kontantgrad
0.77
Gns. volumen
649.56K
Fundamentalt snapshot-pris
5.37

Resultatopgørelse

Post 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Omsætning 320.61M 370.32M 364.21M 386.14M 364.49M
Bruttofortjeneste 214.46M 261.98M 256.72M 265.73M 246.96M
Driftsresultat 4.03M 23.24M 21.64M 30.78M -9.9M
Resultat før afskrivninger 18.21M 36.16M 33.73M 43.83M 29.42M
Nettoresultat 1.84M 14.49M 17.08M 21.12M 107.52M
Basisindtjening pr. aktie 0.04 0.31 0.35 0.43 2.16
Udvandet indtjening pr. aktie 0.04 0.27 0.34 0.43 2.14

Balance

Post 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Samlede aktiver 1.38B 1.41B 1.42B 1.44B 1.39B
Samlede forpligtelser 582.71M 600.07M 624.61M 655.94M 637.44M
Samlet egenkapital 794.09M 805.24M 799.8M 787.75M 753.97M
Kontanter og likvider 198.65M 238.63M 251.79M 264.16M 203.77M
Omsætningsaktiver 522.89M 547.7M 548.14M 571.55M 524.86M
Kortfristet gæld 257M 263.73M 254.44M 283.91M 260.3M

Pengestrøm

Post 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Driftens pengestrøm -3.92M 16.62M 27.48M 35.8M 389K
Investeringspengestrøm -14.29M -9.76M -9.92M 8.79M 181.54M
Finansieringspengestrøm -20.4M -18.5M -26.88M 9.27M -166.3M
Ændring i kontanter -39.98M -13.16M -12.37M 60.39M 16.89M
Type Indberetning Dato Henvisning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 144 — NU SKIN ENTERPRISES, INC. Se indberetning
form 4 Form 4 — Winett James M Se indberetning
edgar index S-8 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 144 — NU SKIN ENTERPRISES, INC. Se indberetning
form 4 Form 4 — CAMPBELL DANIEL W Se indberetning
form 4 Form 4 — CAMPBELL DANIEL W Se indberetning
form 4 Form 4 — CAMPBELL DANIEL W Se indberetning
form 4 Form 4 — Thomas Pisano R. Se indberetning
form 4 Form 4 — Battle Emma S. Se indberetning
form 4 Form 4 — WOODBURY EDWINA D Se indberetning
form 4 Form 4 — WOODBURY EDWINA D Se indberetning
form 4 Form 4 — Zorko Mark A Se indberetning
form 4 Form 4 — Nathanson Laura Se indberetning
form 4 Form 4 — Winett James M Se indberetning
edgar index 8-K — NU SKIN ENTERPRISES, INC. Se indberetning
eight k text 8-K — 8-K Se indberetning
edgar index SD — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 144 — NU SKIN ENTERPRISES, INC. Se indberetning
form 4 Form 4 — Nathanson Laura Se indberetning
edgar index 10-Q — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 8-K — NU SKIN ENTERPRISES, INC. Se indberetning
eight k text 8-K — 8-K Se indberetning
edgar index 8-K — NU SKIN ENTERPRISES, INC. Se indberetning
eight k text 8-K — 8-K Se indberetning
edgar index DEF 14A — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index DEFA14A — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index ARS — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 3 — NU SKIN ENTERPRISES, INC. Se indberetning
form 3 Form 3 — Lantz Chelsea K Se indberetning
edgar index SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 8-K — NU SKIN ENTERPRISES, INC. Se indberetning
eight k text 8-K — 8-K Se indberetning
edgar index 8-K — NU SKIN ENTERPRISES, INC. Se indberetning
eight k text 8-K — 8-K Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
form 4 Form 4 — WOODBURY EDWINA D Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 8-K — NU SKIN ENTERPRISES, INC. Se indberetning
eight k text 8-K — 8-K Se indberetning
form 4 Form 4 — NAPIERSKI RYAN S Se indberetning
form 4 Form 4 — Thomas James D Se indberetning
form 4 Form 4 — Clark Chayce David Se indberetning
form 4 Form 4 — Hatchett Steven Keith Se indberetning
form 4 Form 4 — Keisel Justin S Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
form 4 Form 4 — NAPIERSKI RYAN S Se indberetning
form 4 Form 4 — Thomas James D Se indberetning
form 4 Form 4 — Clark Chayce David Se indberetning
form 4 Form 4 — Hatchett Steven Keith Se indberetning
form 4 Form 4 — Keisel Justin S Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
edgar index 4 — NU SKIN ENTERPRISES, INC. Se indberetning
form 4 Form 4 — NAPIERSKI RYAN S Se indberetning
form 4 Form 4 — Thomas James D Se indberetning
form 4 Form 4 — Clark Chayce David Se indberetning